-
Mashup Score: 8
PURPOSETrimodal therapy (TMT) is the standard treatment for patients with nonmetastatic inflammatory breast cancer (IBC). TMT consists of neoadjuvant systemic therapy, modified radical mastectomy (MRM), and postmastectomy radiation therapy. Although …In the BRIDGES study, @IlanaSchlam @FilipaLynce @darioT_ et al showed the treatment patterns of IBC in low- and middle-income countries and the need for provider education to improve patient care worldwide.
Source: ascopubs.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 8
PURPOSETrimodal therapy (TMT) is the standard treatment for patients with nonmetastatic inflammatory breast cancer (IBC). TMT consists of neoadjuvant systemic therapy, modified radical mastectomy (MRM), and postmastectomy radiation therapy. Although …In the BRIDGES study, @IlanaSchlam @FilipaLynce @darioT_ et al showed the treatment patterns of IBC in low- and middle-income countries and the need for provider education to improve patient care worldwide.
Source: ascopubs.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 8
PURPOSETrimodal therapy (TMT) is the standard treatment for patients with nonmetastatic inflammatory breast cancer (IBC). TMT consists of neoadjuvant systemic therapy, modified radical mastectomy (MRM), and postmastectomy radiation therapy. Although …In the BRIDGES study, @IlanaSchlam @FilipaLynce @darioT_ et al showed the treatment patterns of IBC in low- and middle-income countries and the need for provider education to improve patient care worldwide.
Source: ascopubs.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 3The current global landscape of national cancer strategies: a new review by UICC and ICCP | UICC - 1 month(s) ago
The first global review since 2018 reveals progress in national cancer strategies but highlights persistent gaps in funding, equitable access, and integration of evidence-based interventions.
Source: www.uicc.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 92‘The Opportunities Are Endless’: CU Cancer Center Leader Signs Key International Agreement - 2 month(s) ago
A CU Cancer Center global oncology leader has returned from Mexico, where he signed the first of many agreements with cancer centers in Latin America.
Source: news.cuanschutz.eduCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 13The use of wearable technology in studies in older adults with cancer: a systematic review - 2 month(s) ago
AbstractBackground. Despite the increasing integration of wearable technology in oncology, its application in the care of older adults, representing most p
Source: academic.oup.comCategories: General Medicine News, Oncologists1Tweet-
@OncJournal @SIOGorg @CancerCareMASCC @JCBaltussen @UniLeidenNews @CUCancerCenter @INCMNSZ_Geria The most commonly measured outcome was physical activity 🚶♀️🚶🚶♂️👩🦯 Various wearables were used 📱📟 ⚠️Adherence was only measured in 35% of studies⚠️ But, when assessed it was high, between 75-100% @JCBaltussen @CUCancerCenter https://t.co/73s47Lj99e
-
-
Mashup Score: 8The use of wearable technology in studies in older adults with cancer: a systematic review - 2 month(s) ago
AbstractBackground. Despite the increasing integration of wearable technology in oncology, its application in the care of older adults, representing most p
Source: academic.oup.comCategories: General Medicine News, Oncologists1Tweet-
@OncJournal @SIOGorg @CancerCareMASCC @JCBaltussen @UniLeidenNews @CUCancerCenter @INCMNSZ_Geria The most commonly measured outcome was physical activity 🚶♀️🚶🚶♂️👩🦯 Various wearables were used 📱📟 ⚠️Adherence was only measured in 35% of studies⚠️ But, when assessed it was high, between 75-100% @JCBaltussen @CUCancerCenter https://t.co/73s47Lj99e
-
-
Mashup Score: 655Postseason Information | Los Angeles Dodgers - 4 month(s) ago
The Official Site of Major League Baseball
Source: www.mlb.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 5Time toxicity among older patients with cancer treated with palliative systemic therapy - 5 month(s) ago
Supportive Care in Cancer – The time toxicity of anticancer therapy, defined as days spent with healthcare contact during treatment, represents a critical but understudied outcome. This study aims…
Source: link.springer.comCategories: General Medicine News, Oncologists1Tweet-
@JCBaltussen @MASCC_JSCC @CancerCareMASCC @oncology_bg @guptaarjun90 @csoncol @YoungSIOG @SIOGorg @INCMNSZ_Ensena @INCMNSZ_Geria @INCMNSZ_DirInv Time toxicity is often overlooked, but may offset the small additive gains provided by some therapies. This may be worse in LMICs, where healthcare is sometimes more difficult to access Loved working with @JCBaltussen in this, tell us what you think! https://t.co/yej59z3xAn https://t.co/L6y1iueYcq
-
-
Mashup Score: 5Enrique Soto is running for the SIOG Board of Directors - OncoDaily - 5 month(s) ago
Enrique Soto is running for the SIOG Board of Directors / American Society for Clinical Oncology, Arti Hurria, ASCO, ASCO Connection, cancer, CCF, City of
Source: oncodaily.comCategories: General Medicine News, Oncologists1Tweet
RT @IlanaSchlam: https://t.co/DYEZx1unxN Grateful for amazing global 🌎collaborators that made this possible: @darioT_ @FilipaLynce @stol…